Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a New Tumor Immunity-Related Signature to Assess and Classify the Prognostic Risk of Colorectal Cancer. | Int J Gen Med | 2021 | 34675628 | PubTator, text mining | PubMed |
| Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells. | Adv Sci (Weinh) | 2021 | 34658167 | PubTator, text mining | PubMed |
| MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals. | Front Immunol | 2021 | 34650566 | PubTator, text mining | PubMed |
| STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis. | BMC Oral Health | 2021 | 34649540 | PubTator, text mining | PubMed |
| Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells. | Molecules | 2021 | 34641520 | PubTator, text mining | PubMed |
| An Insight into Sesamolin: Physicochemical Properties, Pharmacological Activities, and Future Research Prospects. | Molecules | 2021 | 34641392 | PubTator, text mining | PubMed |
| A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS). | Int J Mol Sci | 2021 | 34638718 | PubTator, text mining | PubMed |
| Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome. | Int J Mol Sci | 2021 | 34638574 | PubTator, text mining | PubMed |
| Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. | Cancers (Basel) | 2021 | 34638513 | PubTator, text mining | PubMed |
| Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy. | Cancers (Basel) | 2021 | 34638471 | PubTator, text mining | PubMed |
| TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells. | Cancers (Basel) | 2021 | 34638439 | PubTator, text mining | PubMed |
| Identification of tumor microenvironment-associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPE. | Mol Clin Oncol | 2021 | 34631056 | PubTator, text mining | PubMed |
| γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. | Front Immunol | 2021 | 34630403 | PubTator, text mining | PubMed |
| Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma. | J Oncol | 2021 | 34616452 | PubTator, text mining | PubMed |
| A summary of current NKG2D-based CAR clinical trials. | Immunother Adv | 2021 | 34604863 | PubTator, text mining | PubMed |
| Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity. | J Immunother Cancer | 2021 | 34599028 | PubTator, text mining | PubMed |
| Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia. | Cancer Manag Res | 2021 | 34594134 | PubTator, text mining | PubMed |
| Molecular Characteristics, Clinical Implication, and Cancer Immunity Interactions of Pyroptosis-Related Genes in Breast Cancer. | Front Med (Lausanne) | 2021 | 34589498 | PubTator, text mining | PubMed |
| RNA N6 -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential. | Clin Transl Med | 2021 | 34586737 | PubTator, text mining | PubMed |
| Combination strategies to maximize the benefits of cancer immunotherapy. | J Hematol Oncol | 2021 | 34579759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=49